A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2006
11/09/2006	WO2006083799A3 Suspending vehicles comprising a hydrophilic solvent, a hydrophobic solvent, a polymer and the suitable pump-driven dosage form
11/09/2006	WO2006076891A3 Method and device for encapsulating materials in liposomes comprising a freely adaptable membrane structure
11/09/2006	WO2006051153B1 Methods and devices for facile fabrication of nanoparticles and their applications
11/09/2006	WO2006050072B1 Manufacturing process for liposomal preparations
11/09/2006	WO2006047738A3 Dosage forms having a microreliefed surface and methods and apparatus for their production
11/09/2006	WO2006004941A3 Biomaterial
11/09/2006	WO2006002255A3 A pharmaceutical formulation of balaglitazone
11/09/2006	WO2006000228B1 Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention
11/09/2006	WO2005120524A3 Nutritional formulations
11/09/2006	WO2005099694A8 Combination of a heterocyclic compound and an antioxidant and use thereof for treating obesity
11/09/2006	WO2005089711A3 Pharmaceutical formulation containing unmilled flutamide
11/09/2006	WO2005089112A3 Plasma-enhanced functionalization of carbon-containing substrates
11/09/2006	WO2005055955B1 DOSING METHODS FOR ß-D-2’,3’-DIDEOXY-2’,3’-DIDEHYDRO-5-FLUOROCYTIDINE ANTIVIRAL THERAPY
11/09/2006	WO2005055948A3 Epha2, epha4 and lmw-ptp and methods of treatment of hyperproliferative cell disorders
11/09/2006	WO2005049091A3 Antibody-targeted nanoparticulate active agent delivery
11/09/2006	US20060253106 Implantable reservoir and system for delivery of a therapeutic agent
11/09/2006	US20060253105 Troubleshooting accelerator system for implantable drug delivery pumps
11/09/2006	US20060252915 Inhibit the growth of microorganisms in environments with physiological salt concentrations and at the same time have as low as possible a hemolytic activity
11/09/2006	US20060252824 Substance with sedative effect
11/09/2006	US20060252820 Composition for oral administration containing alkylene dioxybenzene derivative
11/09/2006	US20060252815 Novel combination of anticholineric and beta mimetics for the treatment of respiratory diseases
11/09/2006	US20060252804 Flupirtin injectable galenic form
11/09/2006	US20060252718 Sphingolipids polyalkylamine conjugates for use in transfection
11/09/2006	US20060252717 Sphingoid polyalkylamine conjugates for vaccination
11/09/2006	US20060252696 Pharmaceutical composition as solid dosage form and method for manufacturing thereof
11/09/2006	US20060252682 Liquid growth hormone formulation and process of preparation thereof
11/09/2006	US20060251743 Composition for inducing sleep comprising essential oils as active ingredients, a percutaneous pharmaceutical agent comprising thereof, and a process for producing thereof
11/09/2006	US20060251741 Stable, homogeneous natural product extracts containing polar and apolar fractions
11/09/2006	US20060251730 Anti-microbial sanitary ware and method for making the same
11/09/2006	US20060251728 diabetes; insulin resistance; metabolic disorders; treating degeneration of pancreatic beta cells
11/09/2006	US20060251727 Supplemental dietary composition for increasing muscle size, strength, athletic performance and/or exercise capacity
11/09/2006	US20060251726 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
11/09/2006	US20060251725 Aggregation of particle sizes
11/09/2006	US20060251724 Method for preparing thermoformed compositions containing acrylic polymer binders, pharmaceutical dosage forms and methods of preparing the same
11/09/2006	US20060251723 Formulations of a SRC/ABL inhibitor
11/09/2006	US20060251722 Multi-component vitamin and mineral supplement for the optimal absorption of components
11/09/2006	US20060251721 Hydrocodone and acetaminophen; twice-a-day administration; pain relievers
11/09/2006	US20060251720 Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins
11/09/2006	US20060251719 Sustained-release hydrogel preparation
11/09/2006	US20060251718 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
11/09/2006	US20060251717 Controlling dosage; mixture of memantine hydrochloride with cellulose
11/09/2006	US20060251716 Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
11/09/2006	US20060251715 Oral delivery of a botanical
11/09/2006	US20060251714 Pharmaceutical formulations of amyloid inhibiting compounds
11/09/2006	US20060251713 Amino acid sequences capable of facilitating penetration across a biological barrier
11/09/2006	US20060251712 Method and composition for hyperthermally treating cells
11/09/2006	US20060251711 Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating diseases of the respiratory tract of a mammal
11/09/2006	US20060251710 Micelle composition of polymer and passenger drug
11/09/2006	US20060251709 applying a lipid solution to a membrane formation opening provided in a plate portion of a membrane support, that is in contact with aqueous solution, then sandwiching the lipid solution between the aqueous solution and the support layer whose surface is hydrophilic
11/09/2006	US20060251708 Coenzyme q10 containing proliposome and preparation thereof
11/09/2006	US20060251707 Uv stable transdermal therapeutic plaster
11/09/2006	US20060251705 Delivery of tigecycline in the presence of heparin
11/09/2006	US20060251704 Methods and devices for efficacious treatment of aphthous ulcers
11/09/2006	US20060251688 Polyurethane microcapsules containing biocide and process for the preparation thereof
11/09/2006	US20060251687 Agent-encapsulating micro-and nanoparticles, methods for preparation of same and products containing same
11/09/2006	US20060251685 Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye
11/09/2006	US20060251684 Decrease infectivity, morbidity, and/or mortality associated with pathogenic exposure while minimizing microbial resistance, toxicity to the recipient
11/09/2006	US20060251656 New pharmaceutical compositions based on anticholinergics and anti-tnf antibodies
11/09/2006	US20060251641 Method and apparatus for treatment of cardiac disorders
11/09/2006	US20060251630 Encapsulated cell therapy
11/09/2006	US20060251614 Aliphatic amine polymer salts for tableting
11/09/2006	US20060251592 Isoflavone derivatives
11/09/2006	US20060251589 Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
11/09/2006	US20060251588 Delivery of erectile dysfunction drugs through an inhalation route
11/09/2006	US20060251587 Delivery of analgesics through an inhalation route
11/09/2006	US20060251586 Method for the Administration of an Anticholinergic by Inhalation
11/09/2006	US20060251585 Compositon useful for delivery of active agents
11/09/2006	US20060251584 Drug nano-particle, method and apparatus for preparing pharmaceutical preparation using the particle
11/09/2006	US20060251582 Compositions and methods using microspheres and non-ionic contrast agents
11/09/2006	US20060251581 Method for treatment of uterine fibroid tumors
11/09/2006	US20060248665 Encapsulated fragrance materials and methods for making same
11/09/2006	DE202006010988U1 Chewing tablets, useful to stop smoking, comprises a chewing mass of a body-compatible substance that is attached to a section of substrate part
11/09/2006	DE102005020846A1 Administration form for a homeopathically active material comprises a number of administrations with defined dosage which continuously rises from an initial dosage at the start of the administration cycle up to maximum dosage
11/09/2006	CA2608283A1 Pharmaceutical compositions with synchronized solubilizer release
11/09/2006	CA2607777A1 Transdermal absorption enhancer
11/09/2006	CA2607419A1 Granular preparation containing biguanide compound
11/09/2006	CA2607335A1 Filtrate composition with a radiation absorber
11/09/2006	CA2607101A1 Inhalation device containing plural doses of a pharmaceutical composition
11/09/2006	CA2606813A1 Timed, pulsatile release systems
11/09/2006	CA2606740A1 Quinine-containing controlled-release formulations
11/09/2006	CA2606714A1 Non-lithotripsic kidney-stone therapy
11/09/2006	CA2606386A1 Therapeutic compositions
11/09/2006	CA2606151A1 Composition for sleep inducer comprising essential oil as active ingredient, percutaneous sleep inducer comprising thereof, and method for producing thereof
11/09/2006	CA2606073A1 Ophthalmic devices for sustained delivery of active compounds
11/09/2006	CA2605863A1 Cell-surface decoration with active agents
11/09/2006	CA2605473A1 Process for preparing quetiapine and quetiapine fumarate
11/09/2006	CA2605112A1 Solid transdermal therapeutic system comprising uv absorber
11/09/2006	CA2603020A1 Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus
11/09/2006	CA2601067A1 Method of administering a cationic liposomal preparation comprising paclitaxel
11/08/2006	EP1719527A1 Antitumor agent
11/08/2006	EP1719523A1 Protein drug sustained-release microparticle preparation for injection and process for producing the same
11/08/2006	EP1719505A2 Pharmaceutical formulations for dry powder inhalers in the form of hard pellets
11/08/2006	EP1719504A1 Solid transdermal therapeutic system with UV-absorber
11/08/2006	EP1719503A1 Use of debranched starch in extrusion-spheronization pharmaceutical pellets
11/08/2006	EP1719502A1 Composition for easing human childbirth
11/08/2006	EP1719501A1 A powder composition comprising a mixture of a hydrophilic polymer matrix and a divalent inorganic metal
11/08/2006	EP1719492A2 Method and apparatus for blowmolding capsules of polyvinylalcohol and blowmolded polyvinylalcohol capsules
11/08/2006	EP1718788A2 Method for providing antimicrobial composite yarns, composite fabrics and articles made therefrom
11/08/2006	EP1718568A2 Process for preparing water soluble diterpenes and their applications
11/08/2006	EP1718564A2 Method for preparing adjustably bioresorbable sol-gel derived sio2

1 ... 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 ... 2991